Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups

SIMPLE SUMMARY: Angiosarcomas (AS) are rare and aggressive soft tissue sarcomas that can be subdivided in de novo primary AS and secondary AS. They have a very poor prognosis and only limited treatment options are available. Immunotherapy is not registered as treatment for AS. Characterization of th...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ravensteijn, Stefan G., Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Weidema, Marije E., Nederkoorn, Maikel J. L., Bol, Kalijn F., Gorris, Mark A. J., Verrijp, Kiek, Kroeze, Leonie I., de Bitter, Tessa J. J., de Voer, Richarda M., Flucke, Uta E., Desar, Ingrid M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739001/
https://www.ncbi.nlm.nih.gov/pubmed/36497420
http://dx.doi.org/10.3390/cancers14235938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739001/
https://www.ncbi.nlm.nih.gov/pubmed/36497420
http://dx.doi.org/10.3390/cancers14235938

Ejemplares similares